These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors. de Waal EEC; van Zaane B; van der Schoot MM; Huisman A; Ramjankhan F; van Klei WA; Marczin N BMC Anesthesiol; 2018 Dec; 18(1):185. PubMed ID: 30526494 [TBL] [Abstract][Full Text] [Related]
12. Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation. Saha A; Jennings DL; Ning Y; Kurlansky P; Miltiades AN; Spellman JL; Sanchez J; Yuzefpolskaya M; Colombo PC; Takayama H; Naka Y; Takeda K Ann Thorac Surg; 2021 Mar; 111(3):800-808. PubMed ID: 32758558 [TBL] [Abstract][Full Text] [Related]
13. Emerging roles of left ventricular assist device therapy as bridge to transplant in an Asian city with scarce heart transplant donor. Wong KL; Ho KLC; Lee OJ; Lun KS; Bhatia I; Tam WYE; Fan YYK; Au WKT J Thorac Dis; 2021 Oct; 13(10):5717-5730. PubMed ID: 34795921 [TBL] [Abstract][Full Text] [Related]
14. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation. Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186 [TBL] [Abstract][Full Text] [Related]
15. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist. Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460 [TBL] [Abstract][Full Text] [Related]
16. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial. Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726 [TBL] [Abstract][Full Text] [Related]
17. Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation. Truby LK; Takeda K; Farr M; Beck J; Yuzefpolskaya M; Colombo PC; Topkara VK; Mancini D; Naka Y; Takayama H ASAIO J; 2018; 64(1):43-51. PubMed ID: 28777136 [TBL] [Abstract][Full Text] [Related]
18. Relation of Left Ventricular Assist Device Infections With Cardiac Transplant Outcomes. Parikh A; Halista M; Raymond S; Feinman J; Mancini D; Mitter S; Barghash M; Trivieri M; Contreras J; Taimur S; Roldan J; Murphy J; Pawale A; Anyanwu A; Moss N; Lala A; Pinney S Am J Cardiol; 2021 Dec; 160():67-74. PubMed ID: 34615608 [TBL] [Abstract][Full Text] [Related]
19. Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices. Fraser CD; Zhou X; Magruder JT; Suarez-Pierre A; Lui C; Grimm JC; Higgins R; Kilic A J Card Surg; 2019 Jun; 34(6):474-481. PubMed ID: 31045281 [TBL] [Abstract][Full Text] [Related]
20. Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device. Sacks LD; Hollander SA; Zhang Y; Ryan KR; Ford MA; Maeda K; Murray JM; Almond CS; Kwiatkowski DM J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2433-2440. PubMed ID: 30929985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]